Estimation of Excess Deaths Associated with the COVID-19 Pandemic in the United States, March to May 2020

JAMA Internal Medicine

Volumn 180, Issue 10, 2020, Pages 1336-1344

  Weinberger, Daniel M ^a   Chen, Jenny ^b   Cohen, Ted ^a   Crawford, Forrest W ^a,c   Mostashari, Farzad ^d   Olson, Don ^e   Pitzer, Virginia E ^a   Reich, Nicholas G ^f   Russi, Marcus ^a   Simonsen, Lone ^g   Watkins, Anne ^a   Viboud, Cecile ^b  

^a YALE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c YALE SCHOOL OF MANAGEMENT   (United States)

^d Aledade   (United States)

^e NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^f UNIVERSITY OF MASSACHUSETTS   (United States)

^g ROSKILDE UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALL CAUSE MORTALITY; ARTICLE; CAUSE OF DEATH; CORONAVIRUS DISEASE 2019; FLU LIKE SYNDROME; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MORTALITY; NATIONAL HEALTH ORGANIZATION; OBSERVATIONAL STUDY; OUTPATIENT CARE; PANDEMIC; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; SEASONAL VARIATION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; TIME SERIES ANALYSIS; UNITED STATES; ADULT; BETACORONAVIRUS; CORONAVIRUS INFECTION; COST OF ILLNESS; FEMALE; ISOLATION AND PURIFICATION; LABORATORY TECHNIQUE; MALE; PROCEDURES; VIRUS PNEUMONIA;

ADULT; BETACORONAVIRUS; CAUSE OF DEATH; CLINICAL LABORATORY TECHNIQUES; CORONAVIRUS INFECTIONS; COST OF ILLNESS; FEMALE; HUMANS; INFLUENZA, HUMAN; MALE; MORTALITY; PANDEMICS; PNEUMONIA; PNEUMONIA, VIRAL;

EID: 85088389654     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2020.3391     Document Type: Article

References (20)

1. WHO director-general's opening remarks at the media briefing on COVID-19, 11 March 2020. World Health Organization website. Accessed June 19, 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19 - -11-march-2020
2. Li R, Pei S, Chen B, Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020; 368 (6490): 489-493. doi: 10.1126/science.abb3221 32179701
3. Yang Y, Yang M, Shen C, Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. medRxiv. Preprint posted February 17, 2020.
4. Kucirka L, Lauer S, Laeyendecker O, Boon D, Lessler J. Variation in false negative rate of RT-PCR based SARS-CoV-2 tests by time since exposure. medRxiv. Preprint posted April 10, 2020.
5. Serfling RE. Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Rep. 1963; 78 (6): 494-506. doi: 10.2307/4591848 19316455
6. Czaja CA, Miller L, Colborn K, State-level estimates of excess hospitalizations and deaths associated with influenza. Influenza Other Respir Viruses. 2020; 14 (2): 111-121. doi: 10.1111/irv.12700 31702114
7. Buehler JW, Devine OJ, Berkelman RL, Chevarley FM. Impact of the human immunodeficiency virus epidemic on mortality trends in young men, United States. Am J Public Health. 1990; 80 (9): 1080-1086. doi: 10.2105/AJPH.80.9.1080 2382745
8. Simonsen L, Spreeuwenberg P, Lustig R,; GLaMOR Collaborating Teams. Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study. PLoS Med. 2013; 10 (11): e1001558. doi: 10.1371/journal.pmed.1001558 24302890
9. Charu V, Simonsen L, Lustig R, Steiner C, Viboud C. Mortality burden of the 2009-10 influenza pandemic in the United States: improving the timeliness of influenza severity estimates using inpatient mortality records. Influenza Other Respir Viruses. 2013; 7 (5): 863-871. doi: 10.1111/irv.12096 23419002
10. Kniss K, Malcolm B, Sutton P, Brammer L. US pneumonia and influenza mortality surveillance: a new era. Online J Public Health Inform. 2014; 6 (1).
11. National, regional, and state level outpatient illness and viral surveillance. Centers for Disease Control and Prevention FluView Interactive website. Accessed April 9, 2020. https://gis.cdc.gov/grasp/fluview/fluportaldashboard.html
12. National Respiratory and Enteric Virus Surveillance System. Centers for Disease Control and Prevention website. Accessed April 9, 2020. https://www.cdc.gov/surveillance/nrevss/index.html
13. Provisional death counts for coronavirus disease 2019 (COVID-19). National Center for Health Statistics website. Accessed April 10, 2020. https://www.cdc.gov/nchs/nvss/vsrr/COVID19/index.htm
14. The COVID Tracking Project. Accessed April 9, 2020. https://covidtracking.com/
15. Lauer SA, Sakrejda K, Ray EL, Prospective forecasts of annual dengue hemorrhagic fever incidence in Thailand, 2010-2014. Proc Natl Acad Sci U S A. 2018; 115 (10): E2175-E2182. doi: 10.1073/pnas.1714457115 29463757
16. McGough SF, Johansson MA, Lipsitch M, Menzies NA. Nowcasting by bayesian smoothing: a flexible, generalizable model for real-time epidemic tracking. PLoS Comput Biol. 2020; 16 (4): e1007735. doi: 10.1371/journal.pcbi.1007735 32251464
17. Woolf SH, Chapman DA, Sabo RT, Weinberger DM, Hill L. Excess deaths from COVID-19 and other causes, March-April 2020. JAMA. Published online July 1, 2020. doi: 10.1001/jama.2020.11787
18. Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med. 2007; 4 (8): e247. doi: 10.1371/journal.pmed.0040247 17683196
19. Olson DR; New York City Department of Health and Mental Hygiene (DOHMH) COVID-19 Response Team. Preliminary estimate of excess mortality during the COVID-19 outbreak-New York City, March 11-May 2, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69 (19): 603-605. doi: 10.15585/mmwr.mm6919e5 32407306
20. Murray CJL, Lopez AD, Chin B, Feehan D, Hill KH. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet. 2006; 368 (9554): 2211-2218. doi: 10.1016/S0140-6736(06)69895-4 17189032